{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:47:45Z","timestamp":1773798465007,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jrnjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1053\/j.jrn.2024.02.005","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T04:18:16Z","timestamp":1710476296000},"page":"454-462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Effect of Niacinamide Supplementation on Phosphate Concentrations in Dutch Dialysis Patients: A Randomized Crossover Trial"],"prefix":"10.1053","volume":"34","author":[{"given":"Lara","family":"Schepers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inez","family":"Jans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0863-4484","authenticated-orcid":false,"given":"Gerda K.","family":"Pot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arend-Jan","family":"Smilde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia M.","family":"Hofstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole M.","family":"de Roos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2024.02.005_bib1","series-title":"2022 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States","year":"2022"},{"key":"10.1053\/j.jrn.2024.02.005_bib2","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/nep.13904","article-title":"Serum phosphate and mortality in incident dialysis patients in Australia and New Zealand","volume":"26","author":"Tiong","year":"2021","journal-title":"Nephrology"},{"key":"10.1053\/j.jrn.2024.02.005_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2024.02.005_bib4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000443848","article-title":"Association between hemodialysis patient outcomes and compliance with KDOQI and KDIGO targets for mineral and bone metabolism","volume":"132","author":"Djukanovi\u0107","year":"2016","journal-title":"Nephron"},{"key":"10.1053\/j.jrn.2024.02.005_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0144119","article-title":"Nonadherence to medication therapy in haemodialysis patients: a systematic review","volume":"10","author":"Ghimire","year":"2015","journal-title":"PLoS One"},{"key":"10.1053\/j.jrn.2024.02.005_bib6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1681\/ASN.2010090987","article-title":"Rosuvastatin in diabetic hemodialysis patients","volume":"22","author":"Holdaas","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2024.02.005_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/hdi.12315","article-title":"Phosphate binder pill burden, patient-reported non-adherence, and mineral bone disorder Markers: Findings from the DOPPS","volume":"20","author":"Fissell","year":"2016","journal-title":"Hemodial Int"},{"key":"10.1053\/j.jrn.2024.02.005_bib8","article-title":"Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"8","author":"Ruospo","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.jrn.2024.02.005_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2369-9-2","article-title":"A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease","volume":"9","author":"Karamanidou","year":"2008","journal-title":"BMC Nephrol"},{"key":"10.1053\/j.jrn.2024.02.005_bib10","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/ndt\/14.5.1195","article-title":"Nicotinamide inhibits sodium-dependent phosphate cotransport activity in rat small intestine","volume":"14","author":"Katai","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2024.02.005_bib11","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/ndt\/gfh781","article-title":"Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure","volume":"20","author":"Eto","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2024.02.005_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11255-013-0559-z","article-title":"Benefits and harm of niacin and its analog for renal dialysis patients: a systematic review and meta-analysis","volume":"46","author":"He","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1053\/j.jrn.2024.02.005_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40268-013-0024-6","article-title":"Use of nicotinamide to treat hyperphosphatemia in dialysis patients","volume":"13","author":"Lenglet","year":"2013","journal-title":"Drugs R"},{"key":"10.1053\/j.jrn.2024.02.005_bib14","article-title":"Efficacy and safety of nicotinamide on phosphorus metabolism in hemodialysis patients: a systematic review and meta-analysis","volume":"97","author":"Zhang","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"10.1053\/j.jrn.2024.02.005_bib15","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"76","year":"2009","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2024.02.005_bib16","first-page":"58","article-title":"Oral nicotinamide reduces serum phosphorus, increases HDL, and induces thrombocytopenia in hemodialysis patients: a double-blind randomized clinical trial","volume":"31","author":"Shahbazian","year":"2011","journal-title":"Nefrologia"},{"key":"10.1053\/j.jrn.2024.02.005_bib17","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ekir.2020.12.012","article-title":"Efficacy and safety of a novel nicotinamide modified-release formulation in the treatment of refractory hyperphosphatemia in patients receiving hemodialysis\u2014a randomized clinical trial","volume":"6","author":"Ketteler","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1053\/j.jrn.2024.02.005_bib18","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/ndt\/gfac206","article-title":"Modified-release nicotinamide for the treatment of hyperphosphataemia in haemodialysis patients: 52-week efficacy and safety results of the phase 3 randomized controlled NOPHOS trial","volume":"38","author":"Ketteler","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2024.02.005_bib19","doi-asserted-by":"crossref","first-page":"530","DOI":"10.21037\/atm.2020.03.228","article-title":"Investigation of nicotinamide as more than an anti-phosphorus drug in chronic hemodialysis patients: a single-center, double-blind, randomized, placebo-controlled trial","volume":"8","author":"Liu","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1053\/j.jrn.2024.02.005_bib20","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/ndt\/gfx249","article-title":"Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study","volume":"32","author":"Lenglet","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2024.02.005_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00467-015-3208-1","article-title":"Efficacy and safety of nicotinamide in the management of hyperphosphatemia in pediatric patients on regular hemodialysis","volume":"31","author":"El Borolossy","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.jrn.2024.02.005_bib22","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2215\/CJN.04211007","article-title":"A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients","volume":"3","author":"Cheng","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2024.02.005_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0899-9007(95)00067-4","article-title":"Definition of standardized nutritional assessment and interventional pathways in oncology","volume":"12","author":"Ottery","year":"1996","journal-title":"Nutrition"},{"key":"10.1053\/j.jrn.2024.02.005_bib24","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MCO.0000000000000171","article-title":"Latest consensus and update on protein-energy wasting in chronic kidney disease","volume":"18","author":"Obi","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1053\/j.jrn.2024.02.005_bib25","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/089686080902900515","article-title":"The effect of oral niacinamide on plasma phosphorus levels in peritoneal dialysis patients","volume":"29","author":"Young","year":"2009","journal-title":"Perit Dial Int"},{"key":"10.1053\/j.jrn.2024.02.005_bib26","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1523-1755.2004.00482.x","article-title":"Nicotinamide suppresses hyperphosphatemia in hemodialysis patients","volume":"65","author":"Takahashi","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2024.02.005_bib27","doi-asserted-by":"crossref","first-page":"l4378","DOI":"10.1136\/bmj.l4378","article-title":"CONSORT 2010 statement: Extension to randomised crossover trials","volume":"366","author":"Dwan","year":"2019","journal-title":"BMJ"},{"key":"10.1053\/j.jrn.2024.02.005_bib28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/sj.bjp.0707528","article-title":"Nicotinic acid: an old drug with a promising future","volume":"153","author":"Bodor","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1053\/j.jrn.2024.02.005_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.amjcard.2008.02.029","article-title":"Mechanism of action of niacin","volume":"101","author":"Kamanna","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jrn.2024.02.005_bib30","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1681\/ASN.2009050559","article-title":"Intestinal Npt2b plays a major role in phosphate absorption and homeostasis","volume":"20","author":"Sabbagh","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2024.02.005_bib31","first-page":"65","article-title":"Magnesium but not nicotinamide prevents vascular calcification in experimental uraemia","volume":"35","author":"Kaesler","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2024.02.005_bib32","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1681\/ASN.2011121213","article-title":"Npt2b deletion attenuates hyperphosphatemia associated with CKD","volume":"23","author":"Schiavi","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2024.02.005_bib33","first-page":"296","article-title":"Phosphate transport in the duodenum and jejunum of goats and its adaptation by dietary phosphate and calcium","volume":"283","author":"Huber","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1053\/j.jrn.2024.02.005_bib34","first-page":"1466","article-title":"Regulation of rat intestinal Na-dependent phosphate transporters by dietary phosphate","volume":"297","author":"Giral-Arnal","year":"2009","journal-title":"Am J Physiol"},{"key":"10.1053\/j.jrn.2024.02.005_bib35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/j.ajkd.2015.07.035","article-title":"Hyperphosphatemia in dialysis patients: beyond nonadherence to Diet and binders","volume":"67","author":"Sherman","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2024.02.005_bib36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s40620-019-00689-w","article-title":"Phosphate binders in chronic kidney disease: an updated narrative review of recent data","volume":"33","author":"Floege","year":"2020","journal-title":"J Nephrol"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227624000360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227624000360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T21:29:29Z","timestamp":1726608569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051227624000360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1051227624000360"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2024.02.005","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effect of Niacinamide Supplementation on Phosphate Concentrations in Dutch Dialysis Patients: A Randomized Crossover Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Renal Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jrn.2024.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}